Back to Search
RUSSELL POSTIER, MD
MD
Surgery Physician
NPI: 1447228622Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
13176(OK)
Research & Publications (20)
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients.
PMID 15220014·Clin Ther·2004
3-trial
DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancer.
PMID 12588958·J Histochem Cytochem·2003
7-preclinical
Watershed events in the improvement of surgical outcomes in the elderly transplant (QLT) recipients.
PMID 12080897·J Okla State Med Assoc·2002
6-review
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
PMID 18427544·Oncogene·2008
7-preclinical
Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer.
PMID 18047715·BMC Bioinformatics·2007
7-preclinical
Expression profiling identifies microRNA signature in pancreatic cancer.
PMID 17149698·Int J Cancer·2007
4-observational
Tigecycline for the treatment of infections due to resistant Gram-positive organisms.
PMID 16433594·Expert Opin Investig Drugs·2006
6-review
Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.
PMID 16256450·Bone·2006
7-preclinical
[1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats.
PMID 16258367·Pancreas·2005
7-preclinical
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.
PMID 16416732·Am J Clin Pathol·2005
4-observational
Gene activity associated with cancers treated by surgical oncologists.
PMID 14619604·J Okla State Med Assoc·2003
6-review
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
PMID 12851279·JAMA·2003
3-trial
Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma.
PMID 12488200·Am J Surg·2002
8-other
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
PMID 11700399·Crit Care Med·2001
3-trial
Comparison of postoperative outcomes in ulcerative colitis and familial polyposis patients after ileoanal pouch operations.
PMID 11839326·Am J Surg·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 825 NE 10TH ST, OUPB2300
OKLAHOMA CITY, OK 73104 - Phone
- (405) 271-7912
Quick Facts
- NPI
- 1447228622
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile